Haloperidol Decanoate Injection
Product Images NDC 63323-471

Product Visual Gallery

This gallery contains 3 technical images submitted to the FDA as part of the official labeling for Haloperidol Decanoate (NDC 63323-471). Unlike standard consumer photos, these assets often include clinical data figures, molecular chemical structures, and official manufacturer packaging layouts.

As provided by Fresenius Kabi Usa, Llc, these visuals offer a comprehensive scientific overview of the product's physical and chemical identity, aiding pharmacists and researchers in product verification and study.

FDA Label Image

Structural Formula (Hal06 0001 01)

Chemical structure of haloperidol decanoate, showing its detailed molecular configuration with characteristic functional groups and ring structures.*

FDA Label Image

Vial (Hal06 0001 02)

Haloperidol Decanoate Injection 100 mg per mL, 1 mL single-use vial label. The label indicates intramuscular use only and is labeled for prescription use only. The product is manufactured by Fresenius Kabi USA, LLC and carries the NDC 63323-471-41. The label includes the PremierProRx logo.*

FDA Label Image

Pbox (Hal06 0001 03)

Haloperidol Decanoate Injection 100 mg/mL label showing the proprietary name, dosage form (intramuscular injection), strength (100 mg per mL as haloperidol), volume (1 mL), and usage instructions (sterile, Rx only, keep in carton until empty). The label indicates the product is manufactured by Fresenius Kabi USA, LLC.*

* About these descriptions: Image descriptions on this page are generated by automated AI analysis of the product label images from the manufacturer's FDA label submission (SPL). They are provided for reference only and may contain errors or omissions. Always rely on the printed label itself and the official FDA labeling, and consult a pharmacist or healthcare professional with any questions about this product.